Niigata Minamata disease
| Niigata Minamata disease | |
|---|---|
| Synonyms | Methylmercury poisoning |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Ataxia, numbness in the hands and feet, muscle weakness, narrowing of the field of vision, hearing impairment, speech impairment, tremors, mental disturbances |
| Complications | Cerebral palsy, developmental delays in children exposed in utero |
| Onset | Symptoms can appear weeks to months after exposure |
| Duration | Chronic |
| Types | N/A |
| Causes | Methylmercury exposure |
| Risks | Consumption of contaminated fish and shellfish |
| Diagnosis | Clinical diagnosis based on symptoms and history of exposure, blood and urine tests for mercury levels |
| Differential diagnosis | Minamata disease, Hunter-Russell syndrome, other forms of mercury poisoning |
| Prevention | Avoiding consumption of contaminated seafood, monitoring and regulation of industrial discharges |
| Treatment | Chelation therapy, supportive care |
| Medication | N/A |
| Prognosis | Variable; some symptoms may be irreversible |
| Frequency | Rare, localized to areas with industrial mercury pollution |
| Deaths | Not specified |
Niigata Minamata disease is a neurological syndrome caused by severe mercury poisoning. It was first discovered in Niigata Prefecture, Japan, in 1965. The disease is named after Minamata Bay in Kumamoto Prefecture, where a similar outbreak occurred in 1956.
Symptoms[edit]
The symptoms of Niigata Minamata disease include ataxia, numbness in the hands and feet, general muscle weakness, narrowing of the field of vision and damage to hearing and speech. In extreme cases, insanity, paralysis, coma and death follow within weeks of the onset of symptoms.
Cause[edit]
The disease was caused by the release of methylmercury in the industrial wastewater from a factory. This highly toxic chemical bioaccumulated in shellfish and fish in Minamata Bay and the Shiranui Sea, which, when eaten by the local populace, resulted in mercury poisoning.
History[edit]
The outbreak of Niigata Minamata disease and the resultant political and legal battles marked a turning point in Japanese society, leading to changes in the relationship between environmental pollution and public health, and to new laws and agencies dedicated to environmental issues.
See also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


